Trial 1B-12-3


“PRESENT”: Prevention of Recurrence in Early-Stage, Node-Positive Breast Cancer with Low to Intermediate HER2 Expression with NeuVax Treatment.

Type: Prevention
Phase: Phase III
Status: Not Open (Closed)
Treatments: Vaccine
Randomized: Yes
Defintions of terms and FAQ about clinical trials.
Trial Leaders/Researchers:  Christy Russell, M.D.
Other Trial Staff:  Nancy Perez, R.N., Yvonne Flores, D.M., Margarita Carranza, D.M., Jessica Levano, R.N., Kristy Watkins, R.N.

Staff may log in to see study documents.

Click here to see trial eligibility criteria and further details at ClinicalTrials.gov





For further information on a study, please contact the Clinical Investigation Support Office at (323) 865-0451, or clinical.trials@med.usc.edu.

To schedule a consultation with the hospital, please call our New Patient Referrals Office at (323) 865-3300.